EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
+21.78%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$553M
AUM Growth
-$10.4M
(-1.8%)
Cap. Flow
-$116M
Cap. Flow
% of AUM
-20.89%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$56.2M |
| 2 |
Axogen
AXGN
|
+$32.5M |
| 3 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$26.8M |
Sector Composition
| 1 | Healthcare | 97.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
1
DELISTED
Revance Therapeutics, Inc.
RVNC
| $137M | 24.83% |
3,842,047
-750,000
| -16% | -$26.8M |
|
|
ABMD
2
DELISTED
Abiomed Inc
ABMD
| $121M | 21.91% |
646,818
-300,000
| -32% | -$56.2M |
|
|
3
Axogen
AXGN
$774M
| $105M | 18.98% |
3,711,111
-1,150,000
| -24% | -$32.5M |
|
|
CORI
4
DELISTED
Corium International, Inc.
CORI
| $89.9M | 16.25% |
9,353,304
| – | – |
|
|
ENTL
5
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $77.6M | 14.02% |
3,231,656
| – | – |
|
|
ELGX
6
DELISTED
Endologix Inc
ELGX
| $12.8M | 2.31% |
125,747
| – | – |
|
7
MediciNova
MNOV
$59.8M
| $7.57M | 1.37% |
1,170,370
| – | – |
|
8
Gyre Therapeutics
GYRE
$685M
| $1.09M | 0.2% |
10,483
| – | – |
|
|
ACUR
9
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $783K | 0.14% |
1,956,397
| – | – |
|